Leiomyosarcoma (LMS) Completed Phase 2 Trials for Dexamethasone (DB01234)

Back to Leiomyosarcoma (LMS)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

Indication	Status	Phase
DBCOND0118909 (Leiomyosarcoma (LMS))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00060944	A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer	Treatment	Dexamethasone (DB01234) Trabectedin (DB05109)